Akshay Vaishnaw - Net Worth and Insider Trading
Akshay Vaishnaw Net Worth
The estimated net worth of Akshay Vaishnaw is at least $6 Million dollars as of 2024-11-13. Akshay Vaishnaw is the President of Alnylam Pharmaceuticals Inc and owns about 23,289 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $6 Million. Details can be seen in Akshay Vaishnaw's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Akshay Vaishnaw has not made any transactions after 2023-08-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Akshay Vaishnaw
Akshay Vaishnaw Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Akshay Vaishnaw owns 3 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Scholar Rock Holding Corp (SRRK) , and Editas Medicine Inc (EDIT) .
Click here to see the complete history of Akshay Vaishnaw’s form 4 insider trades.
Insider Ownership Summary of Akshay Vaishnaw
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc | 2023-08-04 | SVP & Clinical Research |
SRRK | Scholar Rock Holding Corp | 2019-05-21 | director |
EDIT | Editas Medicine Inc | 2016-07-28 | director |
Akshay Vaishnaw Latest Holdings Summary
Akshay Vaishnaw currently owns a total of 1 stock. Akshay Vaishnaw owns 23,289 shares of Alnylam Pharmaceuticals Inc (ALNY) as of August 4, 2023, with a value of $6 Million.
Latest Holdings of Akshay Vaishnaw
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc | 2023-08-04 | 23,289 | 268.95 | 6,263,577 |
Holding Weightings of Akshay Vaishnaw
Akshay Vaishnaw Form 4 Trading Tracker
According to the SEC Form 4 filings, Akshay Vaishnaw has made a total of 10 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 4,057 shares on August 4, 2023, which brought Akshay Vaishnaw around $753,993.
Insider Trading History of Akshay Vaishnaw
- 1
Akshay Vaishnaw Trading Performance
Akshay Vaishnaw Ownership Network
Ownership Network List of Akshay Vaishnaw
Ownership Network Relation of Akshay Vaishnaw
Akshay Vaishnaw Owned Company Details
What does Alnylam Pharmaceuticals Inc do?
Who are the key executives at Alnylam Pharmaceuticals Inc?
Akshay Vaishnaw is the SVP & Clinical Research of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Yvonne Greenstreet , EVP & Chief Commercial Officer Tolga Tanguler , and CMO & EVP Dev & Med Affairs Pushkal Garg .
Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary
Over the past 18 months, Akshay Vaishnaw made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 52,531 shares made by Yvonne Greenstreet , a net sale of 10,304 shares made by Pushkal Garg , and a net sale of 5,639 shares made by Jeffrey V. Poulton .
In summary, during the past 3 months, insiders sold 15,000 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 15,000 shares. During the past 18 months, 249,128 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 249,128 shares.
Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alnylam Pharmaceuticals Inc Insider Transactions
Akshay Vaishnaw Mailing Address
Above is the net worth, insider trading, and ownership report for Akshay Vaishnaw. You might contact Akshay Vaishnaw via mailing address: 300 Third Street, Cambridge Ma 02139.